MAGELLAN LONGEVITY
HomeResearchStudy library › Long-term systolic blood pressure variability is associated with…
Study summary · Cardiovascular & vascular aging

Is long-term systolic blood pressure variability (SBPV) associated with cardiovascular (CV) outcomes, even after adjusting for mean blood pressure?

In one paragraph

Long-term systolic blood pressure variability, a systematic review and meta-analysis in 9,944,254 subjects (Curr Probl Cardiol 2023, PMID 38103812) — long-term SBPV was associated with an increased risk of all-cause mortality (HR 1.21), CV mortality (HR 1.10), major adverse cardiovascular events (MACE) (HR 1.10), cerebrovascular stroke (HR 1.22), and myocardial infarction (HR 1.13). Scope: 9,944,254 subjects, and the abstract states no limitations.

Source: Curr Probl Cardiol 2023, PMID 38103812 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

Curr Probl Cardiol · 2023 · PMID 38103812 · DOI 10.1016/j.cpcardiol.2023.102343

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Higher long-term systolic blood pressure variability is associated with increased risks of death and cardiovascular events, particularly stroke.

The question

Is long-term systolic blood pressure variability (SBPV) associated with cardiovascular (CV) outcomes, even after adjusting for mean blood pressure?

What they tested

The study aims to evaluate the associations between mean blood pressure adjusted long-term SBPV and CV outcomes, suggesting a potential association.

How they did it

A systematic review and meta-analysis was conducted by searching PubMed, Scopus, and Science Direct on January 4, 2023. The analysis included 43 studies with a total of 9,944,254 subjects.

What they found

Long-term SBPV was associated with an increased risk of all-cause mortality (HR 1.21), CV mortality (HR 1.10), major adverse cardiovascular events (MACE) (HR 1.10), cerebrovascular stroke (HR 1.22), and myocardial infarction (HR 1.13). European populations showed a generally higher risk compared to other continents.

Increased Risk Associated with Long-Term SBPV
Values shown: Hazard Ratio
All-cause mortality1.21
Cerebrovascular stroke1.22
Myocardial infarction1.13
CV mortality1.1
MACE1.1

Hazard ratios indicate the increased risk of various outcomes associated with long-term systolic blood pressure variability.

What it means

Long-term SBPV is associated with all-cause mortality, CV mortality, MACE, myocardial infarction, and stroke. Poor outcomes linked to long-term SBPV appear to be more driven by cerebrovascular events than coronary events.

Limitations

The abstract does not explicitly state limitations of the meta-analysis itself, but notes the questionability of the association after adjusting for mean BP, which the study aimed to address.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“long-term systolic blood pressure variability is associated with all-cause and cardiovascular mortality”— from the published abstract, Curr Probl Cardiol 2023

The paper at a glance

TitleLong-term systolic blood pressure variability is associated with mortality and cardiovascular events: a meta-analysis
JournalCurr Probl Cardiol
Year2023
PMID38103812 ↗
DOI10.1016/j.cpcardiol.2023.102343 ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

24h Ambulatory BP Monitor

Large prospective cohorts and pooled analyses of more than 10,000 people show that ambulatory blood pressure, especially the nighttime and 24-hour average, predicts cardiovascular events and all-cause and cardiovascular mortality more strongly than clinic measurement, and that masked hypertension and high nighttime…

24h Ambulatory BP Monitor

A 24-hour ambulatory blood pressure monitor (ABPM) is a portable, automated device that records blood…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Is long-term systolic blood pressure variability (SBPV) associated with cardiovascular (CV) outcomes, even after adjusting for mean blood pressure? [Plain-English summary of Curr Probl Cardiol 2023, PMID 38103812, DOI 10.1016/j.cpcardiol.2023.102343]. Magellan Longevity. https://magellanlongevity.com/study/d38103812.html
BibTeX
@misc{magellan_d38103812, title = {Is long-term systolic blood pressure variability (SBPV) associated with cardiovascular (CV) outcomes, even after adjusting for mean blood pressure?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/d38103812.html}}, note = {Plain-English summary of PubMed PMID 38103812; DOI 10.1016/j.cpcardiol.2023.102343; Curr Probl Cardiol 2023. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/d38103812.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 38103812 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.